What they do
Centerview Partners is an independent investment bank advising on M&A, board and special-committee matters, restructuring and capital advisory, with offices in New York, London, Paris, Menlo Park and San Francisco.
- Services
- Sell-side M&A, Buy-side M&A, Takeovers and schemes, Independent expert reports, Management buy-outs, Restructuring and insolvency, Debt advice, IPOs and listings, Equity raisings
- Specialties
- healthcare, consumer and retail, energy and power, financial institutions, industrials, real estate, technology, media and telecommunications
- Deal size
- Recorded deals: median A$3.3bn
- Clients
- Corporates, Government and not-for-profit
- Founded
- 2006
From centerviewpartners.com, checked 7 Nov 2026: /about, /capabilities
Deals
Columns
1 of 1 deals
| Advisers | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 2026 | ITM Isotope Technologies Munich SE | – | Telix Pharmaceuticals | Merger | Financial adviser to ITM Isotope Technologies Munich SE (target) | Announced | 3,337.9 | Biotech and pharmaceuticals | Morgan Stanley (buy-side)Sidley Austin (buy-side)Herbert Smith Freehills Kramer (buy-side)Latham & Watkins (sell-side) | Telix Pharmaceuticals and ITM Isotope Technologies Munich SE merger |